Related content

Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients

By Verschueren Kilian   Essche Els   Verschueren Patrick   Taelman Veerle   Westhovens Rene  

Clinical Rheumatology, Vol. 26, Iss. 11, 2007-11 ,pp. : 1969-1971

Springer Publishing Company

Access to resources Recommend Favorite

Interstitial granulomatous dermatitis in rheumatoid arthritis responsive to etanercept

By Zoli Angelo   Massi Guido   Pinnelli Michela   Blasi Lo Cuccio Chiara   Castri Federica   Ferraccioli Gianfranco  

Clinical Rheumatology, Vol. 29, Iss. 1, 2010-01 ,pp. : 99-101

Springer Publishing Company

Access to resources Recommend Favorite

Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis

By Yamamoto Motohisa   Takahashi Hiroki   Wakasugi Hideki   Sukawa Yasutaka   Saito Mayuko   Suzuki Chisako   Naishiro Yasuyoshi   Yamamoto Hiroyuki   Shinomura Yasuhisa   Imai Kohzoh  

Modern Rheumatology, Vol. 17, Iss. 1, 2007-02 ,pp. : 72-74

Springer Publishing Company

Access to resources Recommend Favorite

Tryptophan degradation increases with stage in patients with rheumatoid arthritis

By Schroecksnadel Katharina   Winkler Christiana   Duftner Christian   Wirleitner Barbara   Schirmer Michael   Fuchs Dietmar  

Clinical Rheumatology, Vol. 25, Iss. 3, 2006-05 ,pp. : 334-337

Springer Publishing Company

Access to resources Recommend Favorite

Plasma TNF binding capacity profiles during treatment with etanercept in rheumatoid arthritis

By Gudbrandsdottir S   Bliddal H   Petri A   Terslev L   Danneskiold-Samsoe B   Bjørnhart B   Bendtzen K   Müller K  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 6, 2004-11 ,pp. : 385-388

Informa Healthcare

Access to resources Recommend Favorite